Innovation: Uro Onc: CEASAR Prostate Study

CEASAR Prostate Study

The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study for localized prostate cancer is an ongoing multi-site research study conducting long-term follow-up on more than 3,600 men in the United States diagnosed with localized prostate cancer between 2010 and 2011. David F. Penson, MD, MPH, MMHC and Daniel A. Barocas, M.D., MPH are the principal investigators for this study.

The goal for CEASAR is to learn more about what treatments work best for which patients.

Vanderbilt University Medical Center coordinates the study among six sites in the U.S.:

  • Emory University - Rollins School of Public Health (Georgia Center for Cancer Statistics) 
  • Louisiana State University Health Sciences Center (Louisiana Tumor Registry) 
  • Rutgers University (New Jersey State Cancer Registry) 
  • University of California, San Francisco (CaPSURE: Cancer of the Prostate Strategic Urologic Research Endeavor) 
  • University of Southern California - Keck School of Medicine (Los Angeles Cancer Surveillance Program) 
  • University of Utah (Utah Cancer Registry)

CEASER is funded by the Agency for Healthcare Research and Quality (AHRQ), the National Cancer Institute (NCI), and the Patient-Centered Outcomes Research Institute (PCORI).